Matsumori Y, Yamada H, Nagaseki Y, Shimizu K, et al. Atogepant for the preventive treatment of episodic migraine in Japanese participants: A phase 2/3, randomized, double-blind, placebo-controlled trial with an active treatment extension (RELEASE). Cephalalgia 2025;45:3331024251374569.
PMID: 41002192